Q linea AB (QLINEA) NPV

Sell:0.05 SEKBuy:0.05 SEK0.01 SEK (11.43%)

Prices delayed by at least 15 minutes
Sell:0.05 SEK
Buy:0.05 SEK
Change:0.01 SEK (11.43%)
Prices delayed by at least 15 minutes
Sell:0.05 SEK
Buy:0.05 SEK
Change:0.01 SEK (11.43%)
Prices delayed by at least 15 minutes

Company Information

About this company

Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.

Key people

Stuart Gander
Chief Executive Officer
Christer Samuelsson
Chief Financial Officer
Henrik Jacobson
Chief Operating Officer
Mats Gullberg
Vice President, Research Director
Anders Ljunggren
Managing Director, Manager Project Management Office
Victoria Lerneryd
Manager QA/RA
Jonas Melin
Director Product Development
Karl Skoeld
Director Contract Development
Ulrika Stolpe
Human Resource Manager
Erika Kjellberg Eriksson
Chairman of the Board
Mario Gualano
Deputy Independent Chairperson of the Board
Mats Nilsson
Director
Finn Sander Albrechtsen
Independent Director
Karin Fischer
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Sweden
  • Sector
    Technology
  • Industry
    Scientific & Technical Instr.
  • ISIN
    SE0011527845
  • Market cap
    SEK 228.37m
  • Employees
    97
  • Shares in issue
    4.62bn
  • Exchange
    Stockholm Stock Exchange
  • Index
    SX All Share PI Market Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.